Blog
BrightInsight Raises Significant Capital to Enhance its Regulated Digital Health Platform and Accelerate Global Commercialization
Digital Health is an Opportunity for New Relationships Between Payers, Biopharma, and Medtech
Ambiguity Persists in FDA Regulation of Digital Combination Products
News
Avoid These Mistakes to Accelerate Digital Innovation within Big Biopharma and Medtech
BrightInsight Announces the Launch of a CE-marked Dosing Calculator for Emicizumab
Events
San Francisco - J.P. Morgan 38th Annual Healthcare
BrightInsight will be hosting our 3rd Annual Digital Health Panel at JP Morgan’s Healthcare Conference. This year's panel will dig deeper than what’s on the surface to understand how the world’s top biopharma and medtech companies are investing in digital, discuss how to partner with digital therapeutics and technology leaders and how to disrupt traditional organizations from within.
Las Vegas - Gartner Application Strategies & Solutions Summit
Along with Gregory Brail of Google Cloud and David Kempster of CLEAR, Brightinsight's Paul Schultz will be apart of the panel: Google Cloud - Creating API-Powered Digital Ecosystems to Unlocks New Business Channels.
Boston - Partnership Opportunities in Drug Delivery (PODD)
PODD features sessions on the latest advances in drug delivery science. BrightInsight's Paul Schultz will be apart of the panel: Defining the Value Proposition and Supporting Business Models for Scaled Connected Health Drug Delivery Products.